Chesnara Plc: Fourth acquisition in two years
12 November 2026
Aura Biosciences, Inc. (NASDAQ: AURA) stands out in the biotechnology sector, primarily due to its innovative approach towards treating solid tumors. As a clinical-stage company, Aura..
Materialise NV (NASDAQ: MTLS), a prominent player in the 3D printing industry, is capturing investor attention with its promising upside potential of 72%. The Belgian-based company,..
Quantum-Si Incorporated (QSI), a healthcare sector innovator in the medical devices industry, is making waves with its cutting-edge single-molecule detection platform designed to revolutionize Next Generation..
Alumis Inc. (NASDAQ: ALMS), a clinical-stage biopharmaceutical company, is creating waves in the biotechnology industry with its promising pipeline focused on autoimmune disorders. Despite its current..
aTyr Pharma, Inc. (NASDAQ: ATYR) is making waves in the biotechnology sector with its groundbreaking approach to treating fibrosis and inflammation. Based in San Diego, California,..
Compass Therapeutics, Inc. (NASDAQ: CMPX), a clinical-stage biopharmaceutical company, has captured the attention of investors with its oncology-focused pipeline and a remarkable potential upside of nearly..
For investors keeping a close watch on the healthcare sector, iTeos Therapeutics, Inc. (NASDAQ: ITOS) presents a intriguing opportunity within the biotechnology industry. With a market..
Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its ambitious focus on developing treatments for pulmonary arterial..
Neuronetics, Inc. (NASDAQ: STIM), based in Malvern, Pennsylvania, has carved a niche in the healthcare sector with its innovative NeuroStar Advanced Therapy System. This medical device..
Candel Therapeutics, Inc. (NASDAQ: CADL) is making waves in the biotechnology sector with its innovative approach to cancer treatment through immunotherapy. As the company continues to..
Neurogene Inc. (NASDAQ: NGNE) is capturing the attention of investors with a compelling potential upside of 159.68%. As a clinical-stage biotechnology company, Neurogene is at the..
In the dynamic world of biotechnology, CytomX Therapeutics, Inc. (NASDAQ: CTMX) emerges as a noteworthy player with its innovative approach to cancer treatment. Operating at the..
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands out in the biotechnology industry with its innovative approach to developing vaccines and therapeutics for infectious diseases and rare..
Pacific Biosciences of California, Inc. (NASDAQ: PACB) stands at a significant crossroads in the healthcare sector, offering investors a unique opportunity to engage with a company..
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) stands at a compelling juncture within the biotech sector, showcasing potential opportunities amidst its ongoing clinical developments. With a market cap..
For investors with a keen interest in the biotechnology sector, XOMA Royalty Corporation (XOMA) presents an intriguing opportunity, bolstered by a remarkable potential upside of 135.58%...
Nano-X Imaging Ltd (NASDAQ: NNOX) is an intriguing player in the healthcare sector, specializing in revolutionary medical devices. Headquartered in Petah Tikva, Israel, the company has..
Abeona Therapeutics Inc. (NASDAQ: ABEO) is making waves in the biotechnology sector with its innovative approach to gene and cell therapies aimed at treating life-threatening diseases...
National Research Corporation (NRC) stands as a prominent player in the healthcare sector, specializing in health information services. Headquartered in Lincoln, Nebraska, NRC has carved a..
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), a key player in the biotechnology sector with a focus on immunotherapy and targeted oncology, presents an intriguing proposition for investors...
